Market Eyes LiveVentas, Inc. (VTR) Stock Rating & Analysis
MELANY's data-driven read on Ventas, Inc. · Real Estate Investment Trusts.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care sectors, including almost 100 properties in Canada and the United Kingdom, as it seeks further investment in countries whose healthcare systems are mature and operate similarly to that of the US. It also owns mortgages and other loans contributing about 1% of net operating income.
Why VTR scores 61/100
MELANY scores Ventas, Inc. 61/100 by weighing eight factors. Here is how VTR breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Rich valuation, 28.2x P/FFO
Margins, returns on capital, and balance-sheet strength.
- Conservative balance sheet for a REIT (0.8x debt/equity)
Direction and relative strength of the recent share-price trend.
- Uptrend confirmed, price and 50-day above the 200-day MA
History of beating or missing estimates, and where estimates are heading.
- Distribution well covered, 63% of FFO
What Wall Street price targets and revisions are signalling.
- Leading the REIT complex, +4% vs VNQ over 3 months
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
- Strong risk-adjusted return (Sharpe 1.56)
How the current rate and market regime suits this kind of company.
Key risks for VTR
- Standard interest-rate and property-market risk applies
Tracking VTR
Ventas, Inc. rates Steady right now, so MELANY is not flagging a fresh entry. Create a free account to add VTR to your watchlist and get alerted the moment the rating changes.
How MELANY rates VTR
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Ventas, Inc.'s 61/100 reflects reit factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about VTR
Is Ventas, Inc. (VTR) a buy?
As of 2026-08-25, MELANY rated Ventas, Inc. Steady with a composite score of 61/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Ventas, Inc.'s MELANY score?
Ventas, Inc. (VTR) has a MELANY composite score of 61/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the VTR stock rating calculated?
MELANY scores VTR from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Ventas, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Ventas, Inc. (VTR) Steady with a composite of 61/100 as of 2026-08-25. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the VTR stock price forecast?
MELANY does not publish price targets or forecasts for VTR. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 61/100 across eight factors for Ventas, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is VTR stock overvalued or undervalued?
MELANY's valuation factor currently reads 6/100 for Ventas, Inc., where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives VTR's read.
What price should I buy VTR at?
MELANY is not flagging a fresh entry for VTR at its current Steady rating, so there is no entry zone to publish right now. Watchlisting VTR in the free app gets you alerted the moment that changes.
What are the risks of buying VTR stock?
The top risks MELANY currently flags for Ventas, Inc.: Standard interest-rate and property-market risk applies. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Ventas, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 48/100 for Ventas, Inc., and earnings track record, at 86/100. The 61/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will VTR stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 82/100 for VTR right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this VTR rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-25. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores VTR continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
VTR's live rating and alerts are free either way. The app is our flagship.